文献速递青光眼

脂肪间充质干细胞外泌体miR-146a-5p靶向SMAD4减轻TGF-β2诱导的Tenon囊成纤维细胞转化

Adipose-Derived Mesenchymal Stem Cell Exosome miR-146a-5p Attenuates TGF-β2-Induced Transformation of Human Tenon's Capsule Fibroblasts by Targeting SMAD4.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

本研究探讨人脂肪间充质干细胞外泌体(hADSC-exos)对TGF-β2诱导的人Tenon囊成纤维细胞(HTF)纤维化的作用机制。体外实验显示hADSC-exos可被HTF内化,其携带的miR-146a-5p通过靶向SMAD4抑制TGF-β2触发的HTF增殖、迁移和纤维化;兔小梁切除模型证实其可减轻滤过泡周围组织纤维化和胶原沉积。

要点

  • hADSC-exos可被HTF内化,miR-146a-5p在TGF-β2与hADSC-exos共刺激的HTF中上调最显著。
  • hADSC外泌体miR-146a-5p通过靶向SMAD4抑制TGF-β2诱导的HTF增殖、迁移和纤维化。
  • 兔小梁切除模型中,hADSC外泌体miR-146a-5p减轻滤过泡周围组织纤维化和胶原沉积。

核心结论

  • hADSC外泌体miR-146a-5p通过靶向SMAD4减轻TGF-β2刺激的HTF纤维化反应。

研究设计与样本

  • 体外用透射电镜和纳米颗粒追踪分析鉴定hADSC-exos,PKH67染色和共聚焦检测HTF摄取。
  • 体外用CCK-8和划痕实验检测HTF增殖和迁移,Western blot检测蛋白水平。
  • 用双荧光素酶报告和RNA免疫沉淀验证miR-146a-5p与SMAD4结合,并进行功能获得/缺失研究。
  • 体内用新西兰白兔小梁切除模型检测抗纤维化疗效。

主要发现

  • hADSC-exos可被HTF内化。
  • miR-146a-5p在TGF-β2与hADSC-exos共刺激的HTF中上调最显著。
  • hADSC外泌体miR-146a-5p抑制TGF-β2触发的HTF增殖、迁移和纤维化。
  • 装载miR-146a-5p抑制剂的exosomes加剧纤维化。
  • 体内实验中hADSC外泌体miR-146a-5p减轻滤过泡周围组织纤维化和胶原沉积。

临床怎么用

  • hADSC外泌体miR-146a-5p可能为青光眼滤过术后滤过泡瘢痕化提供潜在干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Conjunctival fibrosis is the major impediment to the success of glaucoma filtration surgery. Exosomes secreted by human adipose-derived mesenchymal stem cells (hADSCs) could alleviate a variety of tissue fibrosis. However, the molecular mechanism of hADSCs-derived exosomes (hADSC-exos) in postoperative glaucoma follicle scarring is still unclear. METHODS: The hADSC-exos were identified by a transmission electron microscope and nanoparticle tracking analysis. The hADSC-exos were traced in vitro by PKH67 staining, and uptake of exosomes by human Tenon's capsule fibroblast (HTF) cells was detected by the confocal method. After co-culturing hADSC-exos and transforming growth factor beta-2 (TGF-β2), HTF proliferation and migration were detected using Cell Counting Kit-8 and wound healing assay. Protein levels were examined using Western blot. The binding between miR-146a-5p and SMAD4 was predicted and verified using dual-luciferase reporter and RNA immunoprecipitation assay. Gain/loss-of-function studies using microRNA (miRNA)-modified exosomes and direct mimic transfection were performed. Anti-fibrotic efficacy was examined by a trabeculectomy model using New Zealand white rabbits in vivo. RESULTS: The hADSC-exos could be internalized by HTFs. The miRNA-146a-5p is the most significantly upregulated in HTFs co-stimulated by TGF-β2 and hADSC-exos. After the screening, miR-146a-5p may be a potential target in HTFs treated with TGF-β2 combined with hADSCs-exos. Furthermore, hADSC exosomal miR-146a-5p inhibited TGF-β2-triggered HTF proliferation, migration, and fibrosis by targeting SMAD4. The miR-146a-5p inhibitor-loaded exosomes exacerbated fibrosis. Meanwhile, hADSC exosomal miR-146a-5p could attenuate fibrosis and collagen deposition in the tissue surrounding the glaucoma postoperative filter vesicles in vivo. CONCLUSIONS: The hADSC exosomal miR-146a-5p attenuated TGF-β2-stimulated HTF fibrotic response by targeting SMAD4.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Bao H, Tang T, Li M, et al. Adipose-Derived Mesenchymal Stem Cell Exosome miR-146a-5p Attenuates TGF-β2-Induced Transformation of Human Tenon's Capsule Fibroblasts by Targeting SMAD4. Invest Ophthalmol Vis Sci. 2026. PMID: 42578587. doi:10.1167/iovs.67.10.26

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。